Oppenheimer says Wall Street is underappreciating IBM’s transition

Oppenheimer initiated IBM at an outperform with a $360 price target (about 24% upside), arguing the company’s pivot to a software-centric model is underappreciated; analyst Param Singh forecasts the software portfolio growing ~10% CAGR over the next two years, driven by automation strength and improving Red Hat performance. He noted consulting revenue inflected positive in Q3 2025 and expects consulting to grow in the low single digits while additional revenue opportunities will come from creating and managing AI applications, which should expand gross and pre-tax margins. Oppenheimer expects a re-rating toward peer multiples as software-led growth and margin expansion become clearer; shares have already risen ~32% year-to-date.

Analysis

Oppenheimer initiated coverage of International Business Machines (IBM) with an outperform rating and a $360 price target, implying roughly 24% upside from current levels; the report highlights a strategic pivot to a software-centric model and notes the stock has rallied 32% year-to-date. Analyst Param Singh projects IBM's software portfolio will grow at about a 10% compound annual growth rate over the next two years, driven by strength in automation and improving performance at Red Hat.

The firm also cites a positive inflection in consulting revenue in Q3 2025 and expects consulting to expand at a low-single-digit CAGR, while identifying incremental revenue opportunities from creation and management of AI applications. Oppenheimer forecasts expansion in gross and pre-tax margins due to a higher software mix, and argues current coverage by legacy hardware/services analysts may leave upside underappreciated.

Key implications are that sustained software growth, continued Red Hat momentum, visible consulting recovery, and evidence of margin expansion are required to justify a re-rating toward peer multiples; absent clear execution, conservative market views could persist. Investors should therefore treat the thesis as execution-dependent and focus on quarter-to-quarter evidence of software revenue, consulting trajectory, AI application wins, and margin improvement as catalyst confirmations.

Key Decisions for Investors

• Consider adding or increasing a position in IBM on the view of a software-driven growth re-rating given Oppenheimer's $360 target, provided due diligence confirms ongoing software and Red Hat momentum
• Require sequential proof points—quarterly software revenue growth near the projected 10% CAGR, sustained consulting inflection, and demonstrable gross/pre-tax margin expansion—before fully committing new capital
• If currently long after the 32% YTD rally, think about trimming or hedging near-term exposure (e.g., protective puts or collars) while retaining a core stake to capture a potential re-rating based on execution
• Monitor AI application contract wins, Red Hat growth metrics, and analyst coverage shifts toward software-centric models as key catalysts that would validate upward valuation revision